BLI
Berkeley Lights, Inc. [BLI] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
BLI Stock Summary
In the News
BLI Financial details
Company Rating
-
Market Cap
86.61M
Income
-124.53M
Revenue
71.82M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
285
Optionable
No
Shortable
Yes
Earnings
07 Aug 2023
P/E
-0.91
Forward P/E
-
PEG
2.49
P/S
1.13
P/B
0.58
P/C
-
P/FCF
-1.42
Quick Ratio
1.62
Current Ratio
2.77
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.04
EPS next Y
-
EPS next Q
-
EPS this Y
31.48%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
26.41%
Revenue last 5Y
20.22%
Revenue Q/Q
-24.05%
EPS Q/Q
-99.84%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-33%
ROE
-63%
ROC
-0.37%
Gross Margin
69%
Oper. Margin
-123%
Profit Margin
-130%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.9797-7.4
52W High
-
52W Low
-
RSI
-
Rel Volume
2.81
Avg Volume
815.46K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
1.35699
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
Company Profile
- Volume Average 815.46K
- Market Capitalization 86.61M
- Employee 285
- CEO Dr. Siddhartha Chandrakant Kadia B.E., M.S., Ph.D.
- Headquarters EmeryVille,CA,US
- IPO Date 2020-07-17
-
Website
https://www.berkeleylights.com 
Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. It serves in North America, the Asia Pacific, and Europe. Berkeley Lights, Inc. was incorporated in 2011 and is headquartered in Emeryville, California.
